adding in @bhsmooth as query was raised about FebriDx expansion...

First 1037 Last

Share
Profile

Follow
FinFree101

1,209 Posts.

646

31/03/21

23:03

Post #: 52189368
Share

Originally posted by danhoff: ↑

I think it is nothing about management. They seem to be managing the company very well, as I can see. They cannot force anyone to buy their product. We seem to be stuck on some approvals. We can only hope the base sales with current approvals in place are growing.

A big issue we have is the lack of liquidity. 1 mill shares ($250k) can drop the share value 10% no problem. That is, a $250k dumper can make the company value drop $15 mill. It is why I like to look at financials to determine value. Not some person(s) who want dump shares for their own personal reasons.

You can see how much price wise AT1 is guided by sentiment. After IPO it tripled 'because' of hype. And it has now crashed because of a lack of hype. You can even see a simple presentation noting 'discussions' with China, USA, Brazil, India caused a 30% spike up in share price (23 to 29).

Where management can be ashamed is if all discussions lead to nothing. I mean if you are discussing 5 deals you hope one will be signed.

To be honest, I check the internet for Lumos and FebriDx daily now. I even wrote Lumos a letter the other day trying to extract some info. I said 'why do you set up business in USA, when you do not have approval to sell your product in USA?'. I was hoping for a confirmation of 'imminent'.

It is really odd. We have all these approval awaiting. We have all these discussion awaiting. But management continue to expand manufacturing. I assume management are not idiots. It would be weird to expand exponentially manufacturing for a product you cannot sell. Maybe we will be able to buy the little finger prick kit (with no bio) in the Reject Shop soon for $1.99.

The main issue is the share price has no method of valuation currently. It is what it is. My SMSF looked better with the share price at 29 cents and not so good at 24 cents. Mind you, I first bought at 41 cents. And I have managed to 'average down' to 28.5. It just needs to 'turn around' (again). But that will only happen with some signatures on deals and some approvals. So here we wait.

And today end of Q. $2 mill or $3 mill or $4 mill in revenue. I wonder. Let us hope for $3mill and a declare of cash flow positive.

Expand

adding in @bhsmooth as query was raised about FebriDx expansion in Media thread.

AT1 has been sending Pascal device shipments (whole containers) to RPS Diagnostics for last few months.

(FYI, RPS Dx is the original biz name, still active and under which international shipments are sent to Lumos Diagnostics@USA)

The most recent shipment's revenue (#HNLTHKA2100133 above - 28 Mar'21) should be in the currently Qtrly numbers pending release...

AT1 Price at posting: 24.0¢ Sentiment: Buy Disclosure: Held
12 Upvote

2 Great analysis

Reply

Top Stories

PTR

Petratherm adds $1.6 to the piggybank ahead of SA titanium drilling program

WR1

Winsome scoping study proposes low-cost operation for Adina lithium project

ALR

Altair Minerals hits high-grade copper and gold at Wee MacGregor, QLD

WMG

Western Mines identifies 2 high-grade zones at Mulga Tank in WA

SNG

Siren Gold boosts antimony resource by 66% to 14.5Kt at Auld Creek, NZ